SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049105
Filing Date
2024-04-26
Accepted
2024-04-26 16:08:11
Documents
8
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A nuvl-def14a-2024.htm DEF 14A 848999
2 GRAPHIC img171548356_0.jpg GRAPHIC 173738
3 GRAPHIC img171548356_1.jpg GRAPHIC 6617
4 GRAPHIC img171548356_2.jpg GRAPHIC 173738
5 GRAPHIC img171548356_3.jpg GRAPHIC 218093
6 GRAPHIC img171548356_4.jpg GRAPHIC 213351
7 GRAPHIC img171548356_5.jpg GRAPHIC 1535826
8 GRAPHIC img171548356_6.jpg GRAPHIC 1309091
  Complete submission text file 0000950170-24-049105.txt   5821236
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40671 | Film No.: 24883683
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)